Alteplase 100MG VI 1S
Ended Awarded Last action
- Contract number
- SPE2DR26FBAJP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $78,158
Award facts
- Contract value 100% obligated
- $78,158.43 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on May 26, 2026, for Alteplase 100mg intravenous solution with a ceiling value of $78,158.43.
Place of performance is Conshohocken, PA. The order has an ultimate completion date of May 27, 2026, and is priced on a firm fixed-price basis. No set-aside was used.
Quick answers
Who was awarded contract SPE2DR26FBAJP?
SPE2DR26FBAJP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 26, 2026.
How much is contract SPE2DR26FBAJP worth?
The government has obligated $78,158 on SPE2DR26FBAJP.
Is contract SPE2DR26FBAJP an order under another contract?
Yes. SPE2DR26FBAJP is a delivery order under SPE2DR25D6028, an indefinite delivery contract.
Was contract SPE2DR26FBAJP competed?
The extent of competition for SPE2DR26FBAJP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award